Zhejiang Hisoar Pharmaceutical Co., Ltd. (SHE:002099)

Market Cap	8.56B -8.3%
Revenue (ttm)	1.86B -1.9%
Net Income	-73.86M
EPS	-0.05
Shares Out	1.56B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	20,556,219
Open	5.37
Previous Close	5.39
Day's Range	5.29 - 5.52
52-Week Range	4.87 - 9.09
Beta	0.36
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 29, 2026

About SHE:002099

Zhejiang Hisoar Pharmaceutical Co., Ltd. engages in the manufacture of pharmaceutical products and dyes in China and internationally. The company offers antibiotics, cardiovascular, hypoglycemic, fine chemicals, formulations, intermediates, and other products. It also provides dyestuff, and intermediates of dyestuff and pigment; and manufactures environmental protection related equipment, medical chemical supplies and appliances, and other chemical intermediates. The company was founded in 1966 and is based in Taizhou, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1966
• Employees: 2,736
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002099

Financial Performance

In 2025, SHE:002099's revenue was 1.86 billion, a decrease of -4.01% compared to the previous year's 1.94 billion. Losses were -91.08 million, -72.42% less than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 3, 2026

Data Sources Report a data error